First Trust Nasdaq Pharmaceuticals ETF (FTXH)

NASDAQ: FTXH · Real-Time Price · USD
26.17
+0.40 (1.55%)
At close: Aug 1, 2025, 4:00 PM
26.69
+0.52 (1.99%)
After-hours: Aug 1, 2025, 5:28 PM EDT
1.55%
Assets$14.21M
Expense Ratio0.60%
PE Ratio14.65
Shares Out550,002
Dividend (ttm)$0.44
Dividend Yield1.68%
Ex-Dividend DateJun 26, 2025
Payout FrequencyQuarterly
Payout Ratio24.66%
Volume787
Open25.79
Previous Close25.77
Day's Range25.79 - 26.17
52-Week Low23.29
52-Week High29.72
Beta0.54
Holdings50
Inception DateSep 20, 2016

About FTXH

Fund Home Page

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.

Asset Class Equity
Category Health
Region North America
Stock Exchange NASDAQ
Ticker Symbol FTXH
ETF Provider First Trust
Index Tracked Nasdaq US Smart Pharmaceuticals Index

Top 10 Holdings

54.06% of assets
NameSymbolWeight
Johnson & JohnsonJNJ8.06%
AbbVie Inc.ABBV7.30%
Pfizer Inc.PFE7.12%
Merck & Co., Inc.MRK6.84%
Bristol-Myers Squibb CompanyBMY5.87%
Gilead Sciences, Inc.GILD3.97%
Amgen Inc.AMGN3.87%
Viatris Inc.VTRS3.82%
Biogen Inc.BIIB3.68%
Zoetis Inc.ZTS3.52%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Jun 26, 2025$0.0892Jun 30, 2025
Mar 27, 2025$0.0992Mar 31, 2025
Dec 13, 2024$0.1304Dec 31, 2024
Sep 26, 2024$0.1218Sep 30, 2024
Jun 27, 2024$0.1284Jun 28, 2024
Mar 21, 2024$0.0676Mar 28, 2024
Full Dividend History

Performance

FTXH had a total return of -6.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.13%.

News

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

2 months ago - Seeking Alpha

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...

5 months ago - Seeking Alpha

Can Health Care Stocks Outperform Again In 2023?

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

2 years ago - Seeking Alpha

Pharma In Transition: Context And Opportunities

The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.

Other symbols: GSKJNJPILLPJPPPHSNYXPH
3 years ago - Seeking Alpha

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

4 years ago - Seeking Alpha

Moving Beyond COVID In Biopharma

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,...

4 years ago - Seeking Alpha

Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...

4 years ago - Seeking Alpha

ETF Spotlight: Pharmaceuticals driven higher by Pfizer

CNBC'S Morgan Brennan takes a look at pharmaceutical as Pfizer's positive vaccine news has led the sector higher.

5 years ago - CNBC Television

The Trouble With Pharma

The Trouble With Pharma

6 years ago - Seeking Alpha